Barcelona, Spain

Oriol Casanovas

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oriol Casanovas. Retrieved from https://idiyas.com/inventor/oriol-casanovas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Oriol Casanovas

Introduction

Oriol Casanovas is a prominent inventor based in Barcelona, Spain. He has made significant strides in the field of cancer research through his innovative work. His contributions are particularly noteworthy in the development of methods for cancer diagnosis and treatment.

Latest Patents

Casanovas holds a patent for his invention titled "Prefoldin 4 in the treatment and diagnosis of cancer." This invention provides methods employing prefoldin-4 (PFDN-4) nucleic acid and polypeptide sequences to detect cancer or a propensity to develop cancer. It also monitors the efficacy of cancer treatments and offers prognostic applications. Furthermore, the invention includes methods for identifying inhibitors of PFDN-4 and treating cancer by inhibiting the expression and/or activity of PFDN-4. He has 1 patent to his name.

Career Highlights

Casanovas is affiliated with the University of California, where he continues to advance his research in cancer treatment and diagnosis. His work has garnered attention for its potential impact on improving patient outcomes in oncology.

Collaborations

Some of his notable coworkers include Joe W Gray and Graeme Hodgson, who have collaborated with him on various research projects.

Conclusion

Oriol Casanovas is a dedicated inventor whose work in cancer research exemplifies the importance of innovation in medical science. His contributions are paving the way for new diagnostic and treatment methods that could significantly benefit patients in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…